NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Derm-Biome Pharmaceuticals, Inc.

Derm-Biome Pharmaceuticals, Inc.

Private
VancouverHealthcare & Life Scienceshttps://derm-biomepharma.com/en/

Last Round

Grant

May 8, 2024

Total Funding Raised

$940,000

Company Overview

Derm-Biome Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing topical therapies for inflammatory skin diseases, precancerous skin conditions, and non-melanoma skin cancers.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaltopical drugsmall-moleculedermatologybiotechdrug discoverydrug developmentpreclinical researchINDinvestigational new drugpharma pipelineatopic dermatitisskin cancerinflammatory skin diseasepruritus treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Derm-Biome Pharmaceuticals, Inc. Comps

Public and private peers based on sector, stage, and business model.

Derm-Biome Pharmaceuticals, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Derm-Biome Pharmaceuticals, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 8, 2024
SeedApr 17, 2024
Pre SeedJul 2, 2020
GrantJul 9, 2019

Key People

Founding team and executive leadership

Gordon Eberwein

CEO

Executive Team

Derm-Biome Pharmaceuticals, Inc. Investors

Notable investors and investment history

Derm-Biome Pharmaceuticals, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Derm-Biome Pharmaceuticals, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Derm-Biome Pharmaceuticals, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersVancouver
Employee Range2
Year Founded2018
Last FundingMay 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.